Xiaotong Yang
- Biomaterials top 2%
- Nanoparticle-Based Drug Delivery 6
- Supramolecular Self-Assembly in Materials 4
- Pharmaceutical Science top 2%
- Drug Solubulity and Delivery Systems 6
- Biomedical Engineering top 5%
- Nanoplatforms for cancer theranostics 15
- Immunology top 10%
- Molecular Biology top 10%
- Advanced biosensing and bioanalysis techniques 4
-
- Corporate Finance and Governance 5
-
- Crystallization and Solubility Studies 5
-
- Crystallography and molecular interactions 5
- Co-authors
- Huile GaoChuan HuMeiyu GengFei‐Fei LiuMin HuangRui LiuLin QinWei Xiao
- Journals
- Acta Pharmaceutica Sinica B (5 papers)Crystal Growth & Design (3 papers)International Journal of Pharmaceutics (3 papers)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Xiaotong Yang
53 papers receiving 2.3k citations
Hit Papers
Peers
Comparison fields: 5 of 147
- Biomaterials 588
- Pharmaceutical Science 207
- Biomedical Engineering 981
- Immunology 280
- Molecular Biology 904
Countries citing papers authored by Xiaotong Yang
This map shows the geographic impact of Xiaotong Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaotong Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaotong Yang more than expected).
Fields of papers citing papers by Xiaotong Yang
This network shows the impact of papers produced by Xiaotong Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaotong Yang. The network helps show where Xiaotong Yang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xiaotong Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 24 | |
| 4 | 2024 | 2 | |
| 5 | 2024 | 0 | |
| 6 | 2024 | 6 | |
| 7 | 2024 | 2 | |
| 8 | 2024 | 2 | |
| 9 | 2024 | 3 | |
| 10 | 2023 | 2 | |
| 11 | 2023 | 5 | |
| 12 | 2023 | 5 | |
| 13 | 2022 | 2 | |
| 14 | 2021 | 2 | |
| 15 | 2021 | 137 | |
| 16 | 2020 | 61 | |
| 17 | 2018 | 5 | |
| 18 | 2018 | 17 | |
| 19 | 2018 | 258 | |
| 20 | 2016 | 15 |
About Xiaotong Yang
Xiaotong Yang is a scholar working on Pharmaceutical Science, Biomaterials, Physical and Theoretical Chemistry, Biomedical Engineering and Accounting, having authored 56 papers that have together received 2.3k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (15 papers), Drug Solubulity and Delivery Systems (6 papers), Nanoparticle-Based Drug Delivery (6 papers), Corporate Finance and Governance (5 papers), Crystallization and Solubility Studies (5 papers), Crystallography and molecular interactions (5 papers), Advanced biosensing and bioanalysis techniques (4 papers) and Supramolecular Self-Assembly in Materials (4 papers). The work is most often cited by research in Biomaterials (588 citations), Pharmaceutical Science (207 citations), Biomedical Engineering (981 citations), Immunology (280 citations) and Molecular Biology (904 citations). Xiaotong Yang has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Huile Gao, Chuan Hu, Meiyu Geng, Fei‐Fei Liu, Min Huang, Rui Liu, Lin Qin, Wei Xiao, Yang Zhou and Xueqin He. Their work appears in journals such as Acta Pharmaceutica Sinica B, Crystal Growth & Design, International Journal of Pharmaceutics, Biomaterials and Chinese Chemical Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.